182 studies found for:    Open Studies | "Protozoan Infections"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
2 Unknown  Babesia Testing in Blood Donors
Condition: Transfusion Transmitted Babesiosis
Intervention: Biological: B.microti diagnostic blood tests
3 Unknown  Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
4 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
5 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
6 Recruiting Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
7 Not yet recruiting Severe and Cerebral Malaria Investigated Through Host Metabolomics
Condition: Severe Malaria
Intervention: Other: Observation
8 Unknown  Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Condition: Cerebral Malaria
Interventions: Drug: inhaled nitric oxide;   Drug: Placebo
9 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
10 Recruiting A Dose-Escalation, Safety and Feasibility Study of Enteral LVT for Seizure Control in Pediatric CM
Conditions: Seizure;   Epilepsy;   Cerebral Malaria
Interventions: Drug: Oral Levetiracetam;   Drug: Standard AED
11 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
12 Unknown  Impact of Insecticide Resistance on Vector Control
Condition: Malaria, Falciparum
Interventions: Other: Indoor residual insecticide spraying (IRS);   Device: Long Lasting Insecticidal Nets (LLIN)
13 Recruiting Computerized Cognitive Rehabilitation in Children After Severe Malaria
Condition: Malaria
Intervention: Behavioral: Computerised cognitive rehabilitation training
14 Not yet recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Condition: Leishmaniasis
Intervention: Drug: Miltefosine
15 Recruiting Parasitic Clearance and Recurrence Rates Among Patients With Vivax Malaria
Condition: Parasitemia
Interventions: Drug: Artemisinin combination therapies (ACT)will be used for Chloroquine resistant P.vivax;   Drug: Chloroquine and Primaquine
16 Not yet recruiting School-Based Treatment With ACT to Reduce Transmission
Condition: Malaria
Intervention: Drug: dihydroartemisinin-piperaquine
17 Recruiting Exercise Training in Patients With Chagasic Heart Disease Without Ventricular Dysfunction
Condition: Chagas Disease
Intervention: Other: Exercise
18 Recruiting Compare the Effectiveness Between Existing Treatment and New Treatment
Condition: P. Falciparum Malaria
Interventions: Drug: Mefloquine+Artesunate;   Drug: Dihydroartemisinin-Piperaquine
19 Recruiting Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia
Condition: Plasmodium Vivax Malaria Without Complication
Interventions: Drug: Artemether-lumefantrine + Primaquine;   Drug: Chloroquine + Primaquine
20 Recruiting The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy
Condition: Malaria Transmission
Interventions: Drug: Artemether Lumefantrine;   Drug: Artemether Lumefantrine 6 dose regimen & single dose of Primaquine on day 0;   Drug: Artemether Lumefantrine 6 dose regimen and single dose Primaquine on day 2

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years